推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 8月25日，中核鈦白發(fā)布了2020年半年度報(bào)告，2020年上半年實(shí)現(xiàn)營(yíng)業(yè)收入1,637,621,259.41元，同比下滑0.91%；實(shí)現(xiàn)歸屬于上市公司股東的凈利潤(rùn)245,140,029.70元，同比增長(zhǎng)14.82%，基本每股收益0.17元。
報(bào)告期末，總資產(chǎn)為5,893,664,277.78元，較上年度末增長(zhǎng)2.74%；歸屬于上市公司股東的凈資產(chǎn)為3,495,059,386.51元，較上年度末增長(zhǎng)6.58%。
據(jù)了解，在新冠肺炎疫情帶來(lái)嚴(yán)峻挑戰(zhàn)的環(huán)境下，中核鈦白嚴(yán)格貫徹黨中央的領(lǐng)導(dǎo)精神，落實(shí)“成本控制，以產(chǎn)定銷(xiāo)的戰(zhàn)略方針，在做好疫情防護(hù)工作的前提下積極推進(jìn)生產(chǎn)經(jīng)營(yíng)工作。各生產(chǎn)基地均保持正常運(yùn)轉(zhuǎn)，在疫情的不利影響下，通過(guò)對(duì)銷(xiāo)售渠道的拓寬，加大出口力度，實(shí)現(xiàn)了產(chǎn)銷(xiāo)平衡，3月份主營(yíng)產(chǎn)品銷(xiāo)售量創(chuàng)造了歷史最高的單月銷(xiāo)量。
此外，中核鈦白主營(yíng)產(chǎn)品金紅石型鈦白粉產(chǎn)銷(xiāo)量均同比增長(zhǎng)；實(shí)現(xiàn)營(yíng)業(yè)總收入16.38億元，較上年同期下降0.91%；利潤(rùn)總額2.99億元，較上年同期增長(zhǎng)14.41%；歸屬于上市公司股東凈利潤(rùn)2.45億元，較上年同期增長(zhǎng)14.82%。
